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Sir,
Medically unexplained physical symptoms (MUPS)
are prevalent in many medical specialties.1 The
associated abnormal illness behaviors usually 
result in over-utilization of health care services.2
We present a patient who suffered from intractable
and medically unexplained low back pain who
was successfully treated.
The patient was a 53-year-old woman who had
completed elementary school in childhood and
who became a housewife. Diabetes mellitus was
diagnosed at the age of 39; it was not managed,
but she was generally healthy in those years.
In 2002, the patient’s husband became involved
in an extramarital affair. Severe conflict between
them occurred in February 2003, and her low back
pain emerged. Unfortunately, her husband fell
into debt and committed suicide in June 2003.
The patient’s low back pain became remarkably
aggravated, she groaned day and night, and her
daily function was seriously affected. All treatments
that she was given in different hospitals over a
period of more than 1 year were in vain, and no
definite physical reason could be found to explain
the pain. She was at last brought to our clinic in
November 2004 for help.
After admission, she showed great suffering
in appearance, and complained about severe low
back pain. Her cognitive function remained intact
and there was no evidence of a psychotic disorder.
However, the patient felt hopeless and frequently
thought about death. She almost ignored all ac-
tivities and spent most of her time crying loudly.
The diagnosis of major depressive disorder was
established, and a comorbid pain disorder was
also specified due to her extraordinary distress.
Thus, we started pharmacologic treatment with
mirtazapine (45 mg/day). Quetiapine (gradually
titrated up to 400 mg/day) was prescribed as an
augmentation of the antidepressant3 and partially
for her sleep disturbance.
She groaned less and started to take more food
about 3 weeks later. We drew up a schedule of
regular exercises in the ward, and tried to teach the
patient to redirect her attention from the pain to
other positive daily activities. She showed good
attendance to the rehabilitation program. Specialist
consultations were also arranged to deal with her
diabetes mellitus. Although diabetic neuropathy
might be a clinical factor of pain, the mild pares-
thesia of her distal limbs seemed unrelated to
the pain recovery, and we discounted their direct
causal relationship. The patient’s low back pain
completely subsided in February 2005 and she
was discharged in March; she was followed-up in
our clinic smoothly.
In this case, the identification of depression
was pivotal. Depression is commonly comorbid
with disorders involving MUPS,4 especially chronic
painful conditions.5 However, the mood disorder
MUPS with masked depression
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may be easily ignored since physical symptoms are
usually the clinical focus. Physicians should strive
to find the “masked” depression in such patients.
There is some biological evidence that dys-
functional serotonergic and noradrenergic neu-
rons could affect both ascending and descending
pathways, causing symptoms of depression and
pain. As a result, the use of dual-action antidepres-
sants, which affect both pathways is preferred.6
Both tricyclic antidepressants and serotonin nor-
adrenergic reuptake inhibitors are effective in pain
management.6,7 Mirtazapine was used in our case
because it is a noradrenergic and specific seroto-
nergic antidepressant. Its positive effect on chronic
pain and concomitant depression was already
approved.8
Psychosocial interventions, especially cognitive-
behavioral therapy (CBT), are also helpful in
managing MUPS.9 Some CBT techniques were in-
troduced in this case, such as focusing on positive
activities. These approaches not only limit the
patient’s abnormal illness behaviors but help to
control symptoms as well.
Briefly, managing MUPS is a complicated issue
including both physical and psychosocial com-
ponents. A practical approach should include 
a combination of dual-action antidepressants
and CBT. Full remission, as in this patient, can be
achieved.
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